A

Atea Pharmaceuticals
D

AVIR

3.20500
USD
0.07
(2.23%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
-2
Market Cap
270,704,104
OverviewSignalsIdeasNews
Related Instruments
    A
    ABUS
    0.01000
    (0.31%)
    3.20000 USD
    A
    ADAP
    0.00500
    (0.84%)
    0.59970 USD
    A
    ASND
    -1.560
    (-1.13%)
    136.110 USD
    C
    CRNC
    0.09500
    (1.25%)
    7.67500 USD
    G
    GERN
    -0.14000
    (-3.84%)
    3.51000 USD
    I
    ICHR
    -0.070
    (-0.23%)
    29.860 USD
    N
    NVAX
    0.05000
    (0.58%)
    8.72000 USD
    X
    XENE
    -0.345
    (-0.89%)
    38.590 USD
    More
News

Title: Atea Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).